Zentalis Pharmaceuticals (ZNTL) has released an update to notify the public and investors about listing compliance status.
The disclosure provides information regarding a notification received from Nasdaq, detailing the relevant content and implications of the notice without referencing specific documents or additional details outside the scope of the summary.
For further insights into ZNTL stock, check out TipRanks’ Stock Analysis page.
